GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (FRA:2HQ) » Definitions » Gross Margin %

Tilray Brands (FRA:2HQ) Gross Margin % : 26.23% (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tilray Brands Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Tilray Brands's Gross Profit for the three months ended in Feb. 2024 was €45.8 Mil. Tilray Brands's Revenue for the three months ended in Feb. 2024 was €174.6 Mil. Therefore, Tilray Brands's Gross Margin % for the quarter that ended in Feb. 2024 was 26.23%.

Warning Sign:

Tilray Brands Inc gross margin has been in long-term decline. The average rate of decline per year is -21.7%.


The historical rank and industry rank for Tilray Brands's Gross Margin % or its related term are showing as below:

FRA:2HQ' s Gross Margin % Range Over the Past 10 Years
Min: 18.59   Med: 24.27   Max: 144.14
Current: 28.01


During the past 12 years, the highest Gross Margin % of Tilray Brands was 144.14%. The lowest was 18.59%. And the median was 24.27%.

FRA:2HQ's Gross Margin % is ranked worse than
79.8% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.74 vs FRA:2HQ: 28.01

Tilray Brands had a gross margin of 26.23% for the quarter that ended in Feb. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Tilray Brands was -21.70% per year.


Tilray Brands Gross Margin % Historical Data

The historical data trend for Tilray Brands's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Gross Margin % Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.27 23.70 24.01 18.59 23.43

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.04 36.46 24.98 24.47 26.23

Competitive Comparison of Tilray Brands's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Gross Margin % falls into.



Tilray Brands Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Tilray Brands's Gross Margin for the fiscal year that ended in May. 2023 is calculated as

Gross Margin % (A: May. 2023 )=Gross Profit (A: May. 2023 ) / Revenue (A: May. 2023 )
=135.2 / 576.954
=(Revenue - Cost of Goods Sold) / Revenue
=(576.954 - 441.751) / 576.954
=23.43 %

Tilray Brands's Gross Margin for the quarter that ended in Feb. 2024 is calculated as


Gross Margin % (Q: Feb. 2024 )=Gross Profit (Q: Feb. 2024 ) / Revenue (Q: Feb. 2024 )
=45.8 / 174.591
=(Revenue - Cost of Goods Sold) / Revenue
=(174.591 - 128.801) / 174.591
=26.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Tilray Brands  (FRA:2HQ) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Tilray Brands had a gross margin of 26.23% for the quarter that ended in Feb. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Tilray Brands Gross Margin % Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (FRA:2HQ) Business Description

Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.

Tilray Brands (FRA:2HQ) Headlines

No Headlines